Most cases of primary salivary mucosa-associated lymphoid tissue lymphoma are associated either with Sjoegren syndrome or hepatitis C virus infection

被引:97
作者
Ambrosetti, A
Zanotti, R
Pattaro, C
Lenzi, L
Chilosi, M
Caramaschi, P
Arcaini, L
Pasini, F
Biasi, D
Orlandi, E
D'Adda, M
Lucioni, M
Pizzolo, G
机构
[1] Univ Verona, Div Ematol, Policlin GB Rossi, Dept Clin & Expt Med, I-37134 Verona, Italy
[2] Univ Verona, Dept Med & Publ Hlth, I-37134 Verona, Italy
[3] Univ Pavia, Dept Pathol, I-27100 Pavia, Italy
[4] Univ Pavia, Div Hematol, I-27100 Pavia, Italy
[5] Univ Verona, Dept Pathol, I-37100 Verona, Italy
关键词
mucosa-associated lymphoid tissue lymphomas; salivary glands; Sjoegren syndrome; hepatitis C virus infection; prognostic factors;
D O I
10.1111/j.1365-2141.2004.04993.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Salivary gland mucosa-associated lymphoid tissue (MALT) lymphomas (SGML) are rare, as are data concerning their behaviour. We analysed clinical features at presentation, particularly the association with Sjoegren syndrome (SS) and hepatitis C virus (HCV) infection, and outcome in 33 cases of SGML diagnosed between March 1985 and April 2003. There were five males and 28 females, with a median age of 61 years. At presentation, 12/33 (36%) had multiple salivary glands or mucosal involvement and four had bone marrow infiltration. Ann Arbor stage was IE in 15 (46%), IIE in four (12%) and IV in 14 patients (42%). Fifteen patients had a history of SS (46%), two of other autoimmune diseases, seven of HCV infection. No case had both SS and HCV. Of the 29 treated patients, 17 received surgery or local radiotherapy; 69% achieved complete remission. Histological transformation occurred in four (12%). Five patients died (three of lymphoma, two of unrelated causes). The 5 year-overall survival (OS), cause-specific survival and progression-free survival was 85 +/- 8%, 94 +/- 6% and 65 +/- 10% respectively. Overall, the disease course was indolent, despite the advanced stage at diagnosis, and local therapy often appeared to be adequate. The only prognostic factors influencing OS were histological transformation and age. The close association of SGML with either autoimmune diseases or HCV infection in our series (73%) confirms their possible role in the pathogenesis of these lymphomas.
引用
收藏
页码:43 / 49
页数:7
相关论文
共 42 条
  • [1] In situ detection of hepatitis C virus RNA in salivary glands
    Arrieta, JJ
    Rodríguez-Iñigo, E
    Ortiz-Movilla, N
    Bartolomé, J
    Pardo, M
    Manzarbeitia, F
    Oliva, H
    Macías, DM
    Carreño, V
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (01) : 259 - 264
  • [2] PRIMARY LYMPHOMA OF MUCOSA-ASSOCIATED LYMPHOID-TISSUE (MALT) IN THE PAROTID-GLAND
    BALM, AJM
    DELAERE, P
    HILGERS, FJM
    SOMERS, R
    VANHEERDE, P
    [J]. CLINICAL OTOLARYNGOLOGY, 1993, 18 (06): : 528 - 532
  • [3] Primary malignant lymphoma of the parotid gland
    Barnes, L
    Myers, EN
    Prokopakis, EP
    [J]. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 1998, 124 (05) : 573 - 577
  • [4] Seroprevalence, viremia and genotype distribution of hepatitis C virus: A community-based population study in northern Italy
    Campello, C
    Poli, A
    Dal Molin, G
    Besozzi-Valentini, F
    [J]. INFECTION, 2002, 30 (01) : 7 - 12
  • [5] CARBONE PP, 1971, CANCER RES, V31, P1860
  • [6] Cavalli F, 2001, Hematology Am Soc Hematol Educ Program, P241
  • [7] Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type
    Conconi, A
    Martinelli, G
    Thiéblemont, C
    Ferreri, AJM
    Devizzi, L
    Peccatori, F
    Ponzoni, M
    Pedrinis, E
    Dell'Oro, S
    Pruneri, G
    Filipazzi, V
    Dietrich, PY
    Gianni, AM
    Coiffier, B
    Cavalli, F
    Zucca, E
    [J]. BLOOD, 2003, 102 (08) : 2741 - 2745
  • [8] HEPATITIS-C VIRUS WITHIN A MALIGNANT-LYMPHOMA LESION IN THE COURSE OF TYPE-II MIXED CRYOGLOBULINEMIA
    DEVITA, S
    SANSONNO, D
    DOLCETTI, R
    FERRACCIOLI, G
    CARBONE, A
    CORNACCHIULO, V
    SANTINI, G
    CROVATTO, M
    GLOGHINI, A
    DAMMACCO, F
    BOIOCCHI, M
    [J]. BLOOD, 1995, 86 (05) : 1887 - 1892
  • [9] Gastric MALT lymphoma: from aetiology to treatment
    Du, MQ
    Isaccson, PG
    [J]. LANCET ONCOLOGY, 2002, 3 (02) : 97 - 104
  • [10] HEPATITIS-C VIRUS-INFECTION IN PATIENTS WITH NON-HODGKINS-LYMPHOMA
    FERRI, C
    CARACCIOLO, F
    ZIGNEGO, AL
    LACIVITA, L
    MONTI, M
    LONGOMBARDO, G
    LOMBARDINI, F
    GRECO, F
    CAPOCHIANI, E
    MAZZONI, A
    MAZZARO, C
    PASERO, G
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1994, 88 (02) : 392 - 394